A comprehensive view of Women's Health Issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Beauty & Personal Care Market Intelligence Service.
Labcorp to acquire selected assets of BioReference Health from OPKO Health focused on clinical diagnostics and reproductive and women's health in the US outside of New York and New Jersey for US$237.5M; acquisition expected to close in H2 2024
Published:
March 28, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Period underwear brand Thinx unveils Get BodyWise, an educational online platform to normalize conversations around periods, offer access to leak protection products; brand's new campaign inspired by AI images combats menstruation, menopause stereotypes
Published:
March 27, 2024
by PR Newswire
|
FDA grants Fast Track designation to J&J's nipocalimab injectable for FNAIT treatment, a potentially life-threatening condition affecting pregnant women's immune response to fetal platelets; it is the only therapy in clinical development for the disorder
Published:
March 26, 2024
by Janssen Pharmaceutical Companies
|
Bayer AG championing innovation, women's health, and sustainability initiatives to set industry benchmarks
Published:
March 22, 2024
by Industry Intelligence Inc.
|
Study finds cervical cancer diagnoses could be reduced by up to 23% if all eligible people got full screening and recommended follow-up tests; up to 20% fewer people would die of this cancer with increased screening participation: University of Michigan
Published:
March 19, 2024
by University of Michigan Institute for Healthcare Policy & Innovation
|
Ask us about our Beauty & Personal Care market view